SG

Active Director Director DIN 02183287
DIN 02183287 First appointment Aug 1991 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Aug 1991
Shareholding value •••• Premium profile

About Sham Goel

Data last updated:

Sham Goel is a Director at Shivalik Rasayan Limited (since 2024), Director at Medicamen Biotech Limited (since 2025) and Director at Medicamen Life Sciences Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Agriculture, Pharma and Manufacturing. The 5 current companies with reported revenue have a combined latest revenue of ₹503 Cr; the largest is Shivalik Rasayan Limited at ₹320 Cr (FY 2025). Earlier, Sham Goel was a Director at Newtek India Private Limited (2013–2014).

DIN 02183287
Primary Designation Director
Industry Agriculture
First Appointment 16 Aug 1991
Oldest Company Age 47 yrs
Largest company Shivalik Rasayan Limited · ₹320 Cr (FY 2025)
Combined revenue ₹503 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shivalik Rasayan Limited L24237UR1979PLC005041
Director13 Aug 20241979₹320 Cr (FY 2025)Active
Medicamen Biotech Limited L74899DL1993PLC056594
Director12 Aug 20251993₹169 Cr (FY 2025)Active
Director12 Aug 20252022₹11.09 Cr (FY 2025)Active
Garne Threads Private Limited U17120DL2014PTC270302
Director12 Aug 20142014₹1.80 Cr (FY 2025)Active
Essem Logistics Limited U63000DL1991PLC045389
Director16 Aug 19911991₹1.42 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Newtek India Private Limited U74899DL1995PTC066874
Director01 Apr 20131995₹13.3 Lakh (FY 2020)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Garne Threads Private Limited
Essem Logistics Limited
Medicamen Life Sciences Private Limited
Medicamen Biotech Limited
Premium access

Shareholding and investment profile for Sham Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sham Goel

Sham Goel currently holds 5 directorships: Shivalik Rasayan Limited (Director, since 13 Aug 2024, revenue ₹320 Cr (FY 2025)); Medicamen Biotech Limited (Director, since 12 Aug 2025, revenue ₹169 Cr (FY 2025)); Medicamen Life Sciences Private Limited (Director, since 12 Aug 2025, revenue ₹11.09 Cr (FY 2025)); Garne Threads Private Limited (Director, since 12 Aug 2014, revenue ₹1.80 Cr (FY 2025)); Essem Logistics Limited (Director, since 16 Aug 1991, revenue ₹1.42 Cr (FY 2023)).

Sham Goel was first appointed on 16 Aug 1991 as Director at Essem Logistics Limited. The most recent appointment on record is 12 Aug 2025 at Medicamen Life Sciences Private Limited.

The 5 current companies of Sham Goel that report revenue have a combined latest revenue of ₹503 Cr: Shivalik Rasayan Limited ₹320 Cr (FY 2025); Medicamen Biotech Limited ₹169 Cr (FY 2025); Medicamen Life Sciences Private Limited ₹11.09 Cr (FY 2025); Garne Threads Private Limited ₹1.80 Cr (FY 2025); Essem Logistics Limited ₹1.42 Cr (FY 2023).

Sham Goel held 1 earlier board appointment: Newtek India Private Limited (Director, 01 Apr 2013 to 26 Aug 2014).

The current boards of Sham Goel's companies include Ashwani Kumar Sharma (Shivalik Rasayan Limited), Parul Choudhary (Shivalik Rasayan Limited), Rahul Bishnoi (Shivalik Rasayan Limited), Ramit Madan (Shivalik Rasayan Limited), Ravi Kumar Bansal (Shivalik Rasayan Limited), Sangeeta Bishnoi (Shivalik Rasayan Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available